Rogerio I Neves Selected Research

pembrolizumab

1/2021

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rogerio I Neves Research Topics

Disease

12	Melanoma (Melanoma, Malignant) 10/2021 - 12/2010
9	Neoplasms (Cancer) 11/2020 - 12/2010
3	Pain (Aches) 05/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2015
2	Seroma 09/2013 - 10/2012
1	Synostosis 10/2016
1	Basal Cell Carcinoma (Rodent Ulcer) 10/2016
1	Vitiligo 01/2015
1	Aneuploidy (Aneuploid) 01/2015
1	Arthritis (Polyarthritis) 01/2015
1	Arthralgia (Joint Pain) 01/2015
1	Hypophysitis 01/2015
1	Epidermodysplasia Verruciformis 01/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014
1	Necrosis 10/2012
1	Hematoma 10/2012
1	Cellulitis 10/2012
1	Abscess 10/2012
1	Wounds and Injuries (Trauma) 10/2012
1	Infections 10/2012
1	Skin Neoplasms (Skin Cancer) 04/2011

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 04/2013
2	IpilimumabIBA 01/2017 - 01/2015
2	Interleukin-2 (IL2)IBA 01/2015 - 12/2010
2	Temozolomide (Temodar)FDA LinkGeneric 01/2015 - 12/2010
2	FHDIBA 09/2013 - 10/2012
2	AllodermIBA 09/2013 - 10/2012
1	pembrolizumabIBA 01/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2018
1	capivasertibIBA 01/2018
1	KetonesIBA 01/2018
1	PLIalphaIBA 01/2018
1	piperidineIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	adavosertibIBA 01/2018
1	HhAntag691IBA 10/2016
1	sonidegibIBA 10/2016
1	ChromatinIBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	InterleukinsIBA 01/2015
1	CytokinesIBA 01/2015
1	Cetuximab (Erbitux)FDA Link 01/2014
1	Capecitabine (Xeloda)FDA Link 01/2014
1	FlexHDIBA 09/2013
1	Phosphotransferases (Kinase)IBA 04/2013
1	Mitogen-Activated Protein Kinase 3IBA 04/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	Protein Kinases (Protein Kinase)IBA 04/2013
1	Aurora Kinase BIBA 04/2013
1	Mutant Proteins (Protein, Mutant)IBA 04/2013
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 04/2013
1	Mitogen-Activated Protein KinasesIBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	Methylene Blue (Methylthioninium Chloride)FDA Link 04/2011
1	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 04/2011
1	Alkylating AgentsIBA 12/2010

Therapy/Procedure

6	Immunotherapy 10/2021 - 01/2015
6	Therapeutics 10/2021 - 12/2010
2	Radiotherapy 01/2017 - 01/2015
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Sutures (Suture) 10/2016
1	Mammaplasty (Breast Reconstruction) 09/2013
1	Punctures 10/2012